Ontario Partners With Biolab Pharma To Open Production Hub In Mississauga
Biolab Pharma develops, manufactures and commercializes prescription medicine and is a leader in cardiology and dermatology drugs. It is one of the ten largest pharmaceutical companies in Brazil.
With support from Ontario's Jobs and Prosperity Fund, the company is retrofitting a 13,000 square foot research development and innovation facility in Mississauga. It will also invest in new equipment and special software to improve its research capabilities. Ontario officials said enhancements will help the company develop and commercialize innovative products for the North American and European markets.
“We are pleased to partner with the Ontario government on this exciting initiative as we expand our operations internationally. Our new facility will help us sharpen our competitive edge and better serve our customers by continually improving and creating innovative products,” Cleiton de Castro Marques, CEO, Biolab Pharma Ltd.
Strengthening Ontario's life sciences sector is part of our plan to create jobs, grow our economy and help people in their everyday lives, a Provincial spokesperson said. Ontario is the largest life sciences jurisdiction in Canada with more than 50 per cent of the country’s total life sciences economic activity. Ontario’s life sciences sector employs approximately 60,000 people. Ontario is investing up to $2.8 million through the Jobs and Prosperity Fund for this project. This is part of a larger overall investment by the company valued at $57.4 million. The project is scheduled for completion in December 2022.
“Our government is excited that Biolab Pharma chose Ontario for its first international site. Today’s announcement is a testament to the province’s competitive and innovative life sciences sector and highly skilled workforce. This is an excellent example of how strategic partnerships can help drive economic growth and create high value jobs in the province,” Brad Duguid, Minister of Economic Development and Growth said.
“Ontario’s private sector is at the forefront of economic growth, tapping into our highly skilled workforce to fill the jobs of tomorrow. Through the Jobs and Prosperity Fund alone, businesses have created or retained more than 35,000 jobs, including 40 announced today at Biolab Pharma. These partnerships contribute to the strong and sustained growth of the Ontario economy, with over 794,500 net new jobs created since the recession. We are proud that our strategic investments are helping businesses across Ontario grow and prosper, Charles Sousa, Minister of Finance, added.
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
How are Uncertain Times Altering Company Location Strategies?
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Infrastructure Investment as an Economic Stimulus Tool
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Site Selection 2020: The Importance of “Regional Depth” with Global Reach